Correlation between high-risk HPV infection and p16/Ki-67 abnormalities in Pap samples in a South Eastern Europe cohort

被引:3
作者
Shalaby, Nevine A. [1 ]
Tudorescu-Morjan, Claudiu [2 ]
Manole, Catalin Gabriel [3 ,4 ]
Iacata, Alexandra-Antonela [2 ]
Popovici, Mirela Laura [2 ]
Grecu, Laura Iulia [2 ]
Curici, Antoanela [2 ,3 ]
机构
[1] Medicover Genet GmbH, Berlin, Germany
[2] Synevo Romania, Bucharest, Romania
[3] Carol Davila Univ Med & Pharm, Dept Cellular & Mol Biol & Histol, Bucharest 050474, Romania
[4] Victor Babes Inst Pathol, Ultrastruct Pathol Lab, Bucharest, Romania
关键词
cervical cancer; diagnostic algorithm; HPV; Ki-67; p16; Pap smear; CYTOLOGY; WOMEN;
D O I
10.1002/jmv.29524
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cervical cancer (CC) is the fourth most common cause of cancer-related deaths amongst women worldwide. CC represents a major global healthcare issue, and Romania ranks the worst in mortality rates amongst EU countries. However, the early detection of CC can be lifesaving. To understand the testing process undergone by women in Romania, we performed a retrospective study, and investigated a cohort of 83785 cervical cases from Romanian women aged 15-70, obtained in private-based opportunistic screening. We examined the correlation between Pap smear results, human papilloma virus (HPV) genotyping, and the expression of cell cycle markers p16 and Ki-67. Analysis of Pap results revealed approximately 10% abnormal cases, of which high-grade squamous intraepithelial lesions constituted 4.9%. HPV genotyping of 12185 cases with available Pap results unveiled a range of high-risk HPV (hrHPV) types associated with cervical abnormalities. Notably, 26% of hrHPV-positive cases showed no observable abnormalities. In a subset of cases with abnormal Pap and a type of hrHPV, P16/Ki-67 double-staining was also positive. This study suggests the importance of an integrated diagnostic algorithm that should consider the HPV genotype, Pap smear, and p16/Ki-67 staining. This algorithm should enhance the CC screening accuracy and its management strategies, particularly in those regions with a high disease burden, such as Romania.
引用
收藏
页数:9
相关论文
共 24 条
[1]   European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition-Summary Document [J].
Arbyn, M. ;
Anttila, A. ;
Jordan, J. ;
Ronco, G. ;
Schenck, U. ;
Segnan, N. ;
Wiener, H. ;
Herbert, A. ;
von Karsa, L. .
ANNALS OF ONCOLOGY, 2010, 21 (03) :448-458
[2]   The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers [J].
Aslan, Deniz L. ;
Crapanzano, John P. ;
Harshan, Manju ;
Erroll, Maria ;
Vakil, Behzad ;
Pirog, Edyta C. .
GYNECOLOGIC ONCOLOGY, 2007, 107 (01) :86-93
[3]   Clinicopathological features of atypical glandular cells, not otherwise specified, on cervicovaginal pap smears [J].
Aytekin, Okan ;
Cakir, Caner ;
Unsal, Mehmet ;
Celik, Fatih ;
Tokalioglu, Abdurrahman Alp ;
Kilic, Fatih ;
Ersak, Burak ;
Codal, Bahadir ;
Kahraman, Alper ;
Gokkaya, Mustafa ;
Ayhan, Sevgi ;
Akar, Serra ;
Cesur, Nesibe ;
Erdogan, Fazli ;
Ozdal, Bulent ;
Oktar, Okan ;
Koc, Sevgi ;
Boran, Nurettin ;
Comert, Gunsu Kimyon ;
Ureyen, Isin ;
Toptas, Tayfun ;
Korkmaz, Vakkas ;
Ustun, Yaprak ;
Tekin, Ozlem Moraloglu ;
Turkmen, Osman ;
Turan, Taner .
CYTOPATHOLOGY, 2023, 34 (02) :130-137
[4]  
Benard VB, 2012, OBSTET GYNECOL, V120, P1117, DOI [10.1097/AOG.0b013e31826e4609, http://10.1097/AOG.0b013e31826e4609]
[5]   Prevalence of higher-grade dysplasia in persistently high-risk human papillomavirus positive, cytology negative women after introduction of the new cervical cancer screening in Germany [J].
Berger, Laura ;
Wolf-Breitinger, Maja ;
Weiss, Christel ;
Tuschy, Benjamin ;
Berlit, Sebastian ;
Suetterlin, Marc ;
Spaich, Saskia .
CANCER CAUSES & CONTROL, 2023, 34 (05) :469-477
[6]   The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology [J].
Beyazit, Fatma ;
Silan, Fatma ;
Gencer, Meryem ;
Aydin, Buket ;
Paksoy, Baris ;
Unsal, Mesut A. ;
Ozdemir, Ozturk .
GINEKOLOGIA POLSKA, 2018, 89 (02) :62-67
[7]   Cervical cancer therapies: Current challenges and future perspectives [J].
Burmeister, Carly A. ;
Khan, Saif F. ;
Schafer, Georgia ;
Mbatani, Nomonde ;
Adams, Tracey ;
Moodley, Jennifer ;
Prince, Sharon .
TUMOUR VIRUS RESEARCH, 2022, 13
[8]   Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis [J].
Clifford, GM ;
Smith, JS ;
Plummer, M ;
Muñoz, N ;
Franceschi, S .
BRITISH JOURNAL OF CANCER, 2003, 88 (01) :63-73
[9]   Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women [J].
Ebisch, Renee M. F. ;
van der Horst, Judith ;
Hermsen, Meyke ;
Rijstenberg, L. Lucia ;
Vedder, Judith E. M. ;
Bulten, Johan ;
Bosgraaf, Remko P. ;
Verhoef, Viola M. J. ;
Heideman, Danielle A. M. ;
Snijders, Peter J. F. ;
Meijer, Chris J. L. M. ;
van Kemenade, Folkert J. ;
Massuger, Leon F. A. G. ;
Melchers, Willem J. G. ;
Bekkers, Ruud L. M. ;
Siebers, Albert G. .
MODERN PATHOLOGY, 2017, 30 (07) :1021-1031
[10]   Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 [J].
Ferlay, J. ;
Steliarova-Foucher, E. ;
Lortet-Tieulent, J. ;
Rosso, S. ;
Coebergh, J. W. W. ;
Comber, H. ;
Forman, D. ;
Bray, F. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) :1374-1403